113 related articles for article (PubMed ID: 17351113)
21. Outcome prediction by immunophenotypic minimal residual disease detection in adult T-cell acute lymphoblastic leukaemia.
Krampera M; Vitale A; Vincenzi C; Perbellini O; Guarini A; Annino L; Todeschini G; Camera A; Fabbiano F; Fioritoni G; Nobile F; Szydlo R; Mandelli F; Foà R; Pizzolo G
Br J Haematol; 2003 Jan; 120(1):74-9. PubMed ID: 12492579
[TBL] [Abstract][Full Text] [Related]
22. Autologous transplantation with peripheral blood stem cells in chronic lymphocytic leukemia. A phase III, randomized, multicenter study. GIMEMA. Gruppo Italiano per le Malattie Ematologiche dell'Adulto. GITMO-Gruppo Italiano Trapianto di Midollo Osseo.
Hematol Cell Ther; 1999 Jun; 41(3):117-25. PubMed ID: 10456442
[No Abstract] [Full Text] [Related]
23. Improvement of dexamethasone sensitivity by chelation of intracellular Ca2+ in pediatric acute lymphoblastic leukemia cells through the prosurvival kinase ERK1/2 deactivation.
Abdoul-Azize S; Dubus I; Vannier JP
Oncotarget; 2017 Apr; 8(16):27339-27352. PubMed ID: 28423696
[TBL] [Abstract][Full Text] [Related]
24. Absence of prognostic impact of CD13 and/or CD33 antigen expression in adult acute lymphoblastic leukemia. Results of the GIMEMA ALL 0496 trial.
Vitale A; Guarini A; Ariola C; Meloni G; Perbellini O; Pizzuti M; De Gregoris C; Mettivier V; Pastorini A; Pizzolo G; Vignetti M; Mandelli F; Foà R
Haematologica; 2007 Mar; 92(3):342-8. PubMed ID: 17339183
[TBL] [Abstract][Full Text] [Related]
25. Extracellular regulated protein kinases 1/2 phosphorylation is required for hepatic differentiation of human umbilical cord-derived mesenchymal stem cells.
Yan Y; Zhu Y; Sun F; Zhang B; Li L; Sun Z; Li W; Qian H; Zhu W; Xu W
Exp Biol Med (Maywood); 2015 Apr; 240(4):534-45. PubMed ID: 25576343
[TBL] [Abstract][Full Text] [Related]
26. Aberrant extracellular signal-regulated kinase (ERK)1/2 signalling in suicide brain: role of ERK kinase 1 (MEK1).
Dwivedi Y; Rizavi HS; Zhang H; Roberts RC; Conley RR; Pandey GN
Int J Neuropsychopharmacol; 2009 Nov; 12(10):1337-54. PubMed ID: 19835659
[TBL] [Abstract][Full Text] [Related]
27. Central role of Fas-associated death domain protein in apoptosis induction by the mitogen-activated protein kinase kinase inhibitor CI-1040 (PD184352) in acute lymphocytic leukemia cells in vitro.
Meng XW; Chandra J; Loegering D; Van Becelaere K; Kottke TJ; Gore SD; Karp JE; Sebolt-Leopold J; Kaufmann SH
J Biol Chem; 2003 Nov; 278(47):47326-39. PubMed ID: 12963734
[TBL] [Abstract][Full Text] [Related]
28. Downmodulation of ERK activity inhibits the proliferation and induces the apoptosis of primary acute myelogenous leukemia blasts.
Lunghi P; Tabilio A; Dall'Aglio PP; Ridolo E; Carlo-Stella C; Pelicci PG; Bonati A
Leukemia; 2003 Sep; 17(9):1783-93. PubMed ID: 12970778
[TBL] [Abstract][Full Text] [Related]
29. Minimal residual disease assessed by multi-parameter flow cytometry is highly prognostic in adult patients with acute lymphoblastic leukaemia.
Ravandi F; Jorgensen JL; O'Brien SM; Jabbour E; Thomas DA; Borthakur G; Garris R; Huang X; Garcia-Manero G; Burger JA; Ferrajoli A; Wierda W; Kadia T; Jain N; Wang SA; Konoplev S; Kebriaei P; Champlin RE; McCue D; Estrov Z; Cortes JE; Kantarjian HM
Br J Haematol; 2016 Feb; 172(3):392-400. PubMed ID: 26492205
[TBL] [Abstract][Full Text] [Related]
30. Clinico-biologic features and treatment outcome of adult pro-B-ALL patients enrolled in the GIMEMA 0496 study: absence of the ALL1/AF4 and of the BCR/ABL fusion genes correlates with a significantly better clinical outcome.
Cimino G; Elia L; Mancini M; Annino L; Anaclerico B; Fazi P; Vitale A; Specchia G; Di Raimondo F; Recchia A; Cuneo A; Mecucci C; Pane F; Saglio G; Foa R; Mandelli F;
Blood; 2003 Sep; 102(6):2014-20. PubMed ID: 12791662
[TBL] [Abstract][Full Text] [Related]
31. Second malignancy after treatment of acute promyelocytic leukemia: experience of GIMEMA trials. Gruppo Italiano Malattie Ematologiche dell'Adulto.
Pagano L; Pulsoni A
Blood; 2002 Aug; 100(4):1514-5. PubMed ID: 12184278
[No Abstract] [Full Text] [Related]
32. Centre effect on treatment outcome for patients with untreated acute myelogenous leukaemia? An analysis of the AML 8A Study of the Leukemia Cooperative Group of the EORTC and GIMEMA. European Organization for Research and Treatment of Cancer (EORTC) Leukemia Cooperative Group and the Gruppo Italiano Malattie Ematologiche Maligne dell'Adulto (GIMEMA).
Keating S; de Witte T; Suciu S; Mandelli F; Damasio E; Willemze R; Morra E; Amadori S; Dardenne M; Vegna ML; Zittoun RA
Eur J Cancer; 1999 Oct; 35(10):1440-7. PubMed ID: 10673975
[TBL] [Abstract][Full Text] [Related]
33. GIMEMA-AIEOPAIDA protocol for the treatment of newly diagnosed acute promyelocytic leukemia (APL) in children.
Testi AM; Biondi A; Lo Coco F; Moleti ML; Giona F; Vignetti M; Menna G; Locatelli F; Pession A; Barisone E; De Rossi G; Diverio D; Micalizzi C; Aricò M; Basso G; Foa R; Mandelli F
Blood; 2005 Jul; 106(2):447-53. PubMed ID: 15677559
[TBL] [Abstract][Full Text] [Related]
34. Outcome of patients with acute myeloid leukemia who failed to respond to a single course of first-line induction therapy: a GIMEMA study of 218 unselected consecutive patients. Gruppo Italiano Malattie Ematologiche Maligne dell'Adulto.
Liso V; Iacopino P; Avvisati G; Petti MC; Broccia G; Carotenuto M; Falda M; Fazi P; Lazzarino M; Leoni P; Mirto S; Pucci G; Nobile F; Nosari AM; Specchia G; Stasi R; Tabilio A; Mandelli F
Leukemia; 1996 Sep; 10(9):1443-52. PubMed ID: 8751460
[TBL] [Abstract][Full Text] [Related]
35. Elastin peptides activate extracellular signal-regulated kinase 1/2 via a Ras-independent mechanism requiring both p110gamma/Raf-1 and protein kinase A/B-Raf signaling in human skin fibroblasts.
Duca L; Lambert E; Debret R; Rothhut B; Blanchevoye C; Delacoux F; Hornebeck W; Martiny L; Debelle L
Mol Pharmacol; 2005 Apr; 67(4):1315-24. PubMed ID: 15653554
[TBL] [Abstract][Full Text] [Related]
36. Caspase 2 and caspase 3 as predictors of complete remission and survival in adults with acute lymphoblastic leukemia.
Faderl S; Thall PF; Kantarjian HM; Talpaz M; Harris D; Van Q; Beran M; Kornblau SM; Pierce S; Estrov Z
Clin Cancer Res; 1999 Dec; 5(12):4041-7. PubMed ID: 10632337
[TBL] [Abstract][Full Text] [Related]
37. hCG activates Epac-Erk1/2 signaling regulating Progesterone Receptor expression and function in human endometrial stromal cells.
Tapia-Pizarro A; Archiles S; Argandoña F; Valencia C; Zavaleta K; Cecilia Johnson M; González-Ramos R; Devoto L
Mol Hum Reprod; 2017 Jun; 23(6):393-405. PubMed ID: 28333280
[TBL] [Abstract][Full Text] [Related]
38. Front-line treatment of acute promyelocytic leukemia with AIDA induction followed by risk-adapted consolidation for adults younger than 61 years: results of the AIDA-2000 trial of the GIMEMA Group.
Lo-Coco F; Avvisati G; Vignetti M; Breccia M; Gallo E; Rambaldi A; Paoloni F; Fioritoni G; Ferrara F; Specchia G; Cimino G; Diverio D; Borlenghi E; Martinelli G; Di Raimondo F; Di Bona E; Fazi P; Peta A; Bosi A; Carella AM; Fabbiano F; Pogliani EM; Petti MC; Amadori S; Mandelli F;
Blood; 2010 Oct; 116(17):3171-9. PubMed ID: 20644121
[TBL] [Abstract][Full Text] [Related]
39. Prolonged extracellular signal-regulated kinase 1/2 activation during fibroblast growth factor 1- or heregulin beta1-induced antiestrogen-resistant growth of breast cancer cells is resistant to mitogen-activated protein/extracellular regulated kinase kinase inhibitors.
Thottassery JV; Sun Y; Westbrook L; Rentz SS; Manuvakhova M; Qu Z; Samuel S; Upshaw R; Cunningham A; Kern FG
Cancer Res; 2004 Jul; 64(13):4637-47. PubMed ID: 15231676
[TBL] [Abstract][Full Text] [Related]
40. Epigallocatechin-3-gallate (EGCG) inhibits PC-3 prostate cancer cell proliferation via MEK-independent ERK1/2 activation.
Albrecht DS; Clubbs EA; Ferruzzi M; Bomser JA
Chem Biol Interact; 2008 Jan; 171(1):89-95. PubMed ID: 17931610
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
